comparemela.com

Latest Breaking News On - Hf rose ch0042615283 - Page 1 : comparemela.com

DOCMORRIS : Morgan Stanley remains Neutral

Morgan Stanley s research confirms his advice and maintains his neutral opinion on the stock. The target price is being increased from CHF 31 to CHF 37. | May 23, 2023

DOCMORRIS : Berenberg reiterates its Neutral rating

In a research note published by Gerhard Orgonas, Berenberg gives a Neutral rating to the stock. The target price is lowered from CHF 60 to CHF 40. | May 17, 2023

ZUR ROSE GROUP : Jefferies reiterates its Buy rating

Alexander Thiel from Jefferies retains his positive opinion on the stock with a Buy rating. The target price continues to be set at CHF 60. | April 20, 2023

ZUR ROSE GROUP : Baader Bank reiterates its Buy rating

Volker Bosse from Baader Bank retains his positive opinion on the stock with a Buy rating. The target price is still set at CHF 45. | April 20, 2023

ZUR ROSE GROUP : Warburg Research reiterates its Buy rating

In a research note, Warburg Research analyst Michael Heider has maintained his recommendation on the stock with a Buy rating. The target price is unchanged and still at CHF 80. | April 20, 2023

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.